Literature DB >> 22408033

Cancer in cardiovascular drug trials and vice versa: a personal perspective.

Marc A Pfeffer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22408033     DOI： 10.1093/eurheartj/ehs014

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  2 in total

1.  Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.

Authors:  Matthew T Roe; Derek D Cyr; Debra Eckart; Phillip J Schulte; Michael A Morse; Kimberly L Blackwell; Neal E Ready; S Yousuf Zafar; Anne W Beaven; John H Strickler; Jane E Onken; Kenneth J Winters; Lisa Houterloot; Dmitry Zamoryakhin; Stephen D Wiviott; Harvey D White; Dorairaj Prabhakaran; Keith A A Fox; Paul W Armstrong; E Magnus Ohman
Journal:  Eur Heart J       Date:  2015-12-05       Impact factor: 29.983

2.  Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-IT.

Authors:  Robert P Giugliano; Baris Gencer; Stephen D Wiviott; Jeong-Gun Park; Charles S Fuchs; Wolfram Goessling; Thomas A Musliner; Andrew M Tershakovec; Michael A Blazing; Robert Califf; Christopher P Cannon; Eugene Braunwald
Journal:  JACC CardioOncol       Date:  2020-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.